Kelly Lawrence W & Associates’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,800
Closed -$274K 177
2022
Q3
$274K Hold
10,800
0.08% 75
2022
Q2
$359K Buy
+10,800
New +$459K 0.1% 65

Other funds holding TDOC

Kelly Lawrence W & Associates's TDOC Position: Q4 2022 in Review

Kelly Lawrence W & Associates sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 10,800 shares — an estimated $274K sold.

Kelly Lawrence W & Associates first reported a position in TDOC in Q2 2022 and held it in 2 quarters. The position peaked at $359K in Q2 2022. 444 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Kelly Lawrence W & Associates reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 10,800 Teladoc Health shares in Q4 2022, an estimated $274K.
  • Kelly Lawrence W & Associates first reported a position in Teladoc Health in Q2 2022 and held it in 2 quarters.
  • Kelly Lawrence W & Associates's Teladoc Health position peaked at $359K in Q2 2022.
  • 444 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Kelly Lawrence W & Associates's 13F filing for Q4 2022, filed 14 Feb 2023.